News organizations are considering the next phase of the controversial health law. While legal and legislative efforts to overturn the health care law outright are likely to wane, big battles are still expected over future changes or specific aspects of the current program.
Politics: Obamacare now seems safe. The battle for its future continues.
For once, Democrats and Republicans are delivering the same message on Obamacare: The historic healthcare law is here to stay. But so do the partisan battles over the future of the law, even after the last shreds of the GOP’s efforts to repeal the affordable care law appeared to have been demolished by Supreme Court decision 7-2. Thursday affirming the law for the third time. (Luthi, 17/6)
The New York Times: Obamacare is here to stay. Prepare for new healthcare battles
The declining repeal effort gave Democrats their first chance in a decade to push forward a new campaign: to move the country forward towards a system of universal health coverage. It feels like the end of a period when Democrats played a steadfast defense, battling legislative and legal challenges. Their recent expansion of health insurance subsidies has enjoyed wide support within the party. The stimulus package Democrats passed in January spent $ 34 billion to make coverage more affordable for nearly all Americans who buy their own health plan. This change, however, was temporary and is expected to expire at the end of 2022. (Sanger-Katz and Kliff, 6/17)
The Atlantic: the next major challenge for affordable care law
The Supreme Court’s rejection of the latest effort to dismantle the Affordable Care Act does not mark the end of litigation over the constitutionality of the law. The next big file has already been filed, and it is a clash between an obscure constitutional provision and the law’s guarantee of zero dollar coverage for prevention services. The stakes will be lower this time around: the whole law is not threatened. But they are still important. If plaintiffs win, insurers could force their clients to pay out of pocket for contraception, breastfeeding equipment and supports, and drugs to prevent HIV infection. They might even start charging people for COVID-19 vaccines, including boosters. This time around, opponents of the law have a good chance of success. (Bagley, 6/17)
NBC News: What now? Congress envisions new era of health policy after survival of Obamacare
Lawmakers in Congress wondered what the new era of federal health care policy would look like after the Supreme Court on Thursday dismissed Obamacare’s latest existential challenge. Democrats said the next step was to build on the sprawling 2010 law, which affected almost every aspect of the healthcare system, by pushing policies to cut costs. (Kapur, 17/6)
AP: GOP needs a new health care goal; “Obamacare” survives again
Along with the gradual but decisive acceptance of the law by the public, court rulings and legislative defeats underscore that the law, passed in 2010 despite overwhelming opposition from the GOP, is likely secure. And it highlights a remarkable progression in the measure of political accountability that cost control of the House of Democrats just months after its enactment to a widely accepted foundation of the medical system, providing care what the government says. be more than 30 million people. “The affordable care law remains the law of the land,” President Joe Biden said, using the more formal name of the law, after the court ruled that Texas and other GOP-led states no. ‘had no right to sue in federal court. (Fram, 6/18)
Axios: ACA Supreme Court ruling saves Republicans from themselves
The Supreme Court saved the healthcare system from imploding Thursday by dismissing a Republican challenge to the Affordable Care Act. But it also saved the GOP itself from another wave of chaos within the party. Most GOP lawmakers privately admit (and some will even say publicly) that they no longer want to deal with health care. The problem is generally not good for them with voters – as they learned it the hard way after failing to repeal the ACA in 2017. (Treene, Owens and Mucha, 6/17)
The Washington Post: As High Court confirms Obamacare, both sides rush to recalibrate
A conservative Supreme Court’s decision to uphold the Affordable Care Act could mark the end of a bitter 11-year campaign to get rid of the law, as both sides immediately began scrambling to recalibrate their strategies with the feeling that the political reality of health care has been steadfastly altered. Some Republicans conceded Thursday that after a decade of repeal votes, political campaigns and court challenges, their quest to overturn the entire law is likely dead. Faced with a 7-2 ruling that marked the third time the High Court has preserved the law, some members of the GOP in Congress have suggested they would instead start plotting legislatively to narrow parts of it. (Goldstein, Viser and DeBonis, 6/17)
The Wall Street Journal: Why is the ACA still controversial 11 years after the passing of the healthcare law known as Obamacare?
Republicans have argued that the government-backed extension of the law’s coverage is too expensive. Indeed, some Republican-led states, including Texas and Florida, have refused to expand their Medicaid programs under the ACA. They also opposed some of the ACA’s prescriptive rules, saying consumers should have more freedom to choose the types of plans they want, even if those are limited or don’t cover certain things. Some also opposed provisions in the law that deal with reproductive issues, including a mandate that employer plans typically cover contraception. (Matthew, 17/6)
The Wall Street Journal: The Affordable Care Act: A Brief History
Since its passage in 2010, the Affordable Care Act has grown to provide health coverage to more than 31 million people when its Medicaid expansion is included, and has survived three Supreme Court challenges. Here is a look at the notable changes the law has seen over the years. (Armor, 17/6)
Modern healthcare: ACA Supreme Court ruling could accelerate biosimilar development
The Supreme Court’s vote to keep the Affordable Care Act Thursday was greeted with applause from payers and providers – and the biosimilar drug development industry. While ACA opponents have widely criticized the expansion of insurance law and coverage mandates, rescinding the law would have untangled the federal framework for biosimilar review and approval. , as well as the litigation guidelines that support the industry, said Meghan Rose Smith, executive director of biosimilars. Forum, a business group that applauded the Supreme Court ruling. In the United States, biosimilars provide a lower cost alternative to some 30 brand name biologics on the market today. (Tepper, 6/17)
This is part of the KHN Morning Briefing, a summary of coverage of health policies by major news organizations. Sign up for an email subscription.